Parkinson 's disease is a chronic progressive neurological disorder in which cells are slowly lost in the brain over the years. The fact that cells are lost makes it a neurodegenerative disorder fitting in the same category as Alzheimer disease. A person with Parkinson’s disease can also experience a wide range of physical and psychological symptoms, including depression, constipation, problems sleeping (insomnia), loss of sense of smell (anosmia) and memory problems. ()
The three main symptoms of Parkinson’s disease are:
- Tremor (involuntary shaking of particular parts of the body)
- Slow movement (Bradykinesia)
- Stiff and inflexible muscles ()
Parkinson 's disease usually develops later on in life, commonly between the ages of 40-80, but also occurs in younger and older individuals. Unfortunately there is no current cure or any definitive therapy which has been shown to slow the progression or prevent the disease. Levadopa is the most standard treatment for neurological disease, nearly all patients showed signs of improvement when Levadopa is used.
Parkinson’s disease affects many area of the brain, this is because several different cells types degenerate and many different systems are affected. The various different chemical systems affected in the brain are: Substancia Negra, Locus Cereleus, Raphe Nuclei, Ventral Tegmental Area and Nuclues Basalus. () The area that is most affected in Parkinson’s disease, is the Substancia Negra. The cell in this part of the brain produce the neurotransmitter Dopamine. Generally about 50% of the dopamine producing cells have degenerated before motor symptoms of the Parkinson’s disease began. The dopamine released in the Substancia Negra are released in a physiological fashion in order to ...
... middle of paper ...
... lost in Parkinson 's. Levodopa is given with benserazide or carbidopa, to make sure it can enter the brain more efficiently. Benserazide plus levodopa is known as co-beneldopa. Carbidopa plus levodopa is known as co-careldopa. There are branded and unbranded forms of levodopa available. These include:
- co-beneldopa (Madopar, Madopar CR)
- co-careldopa (Caramet CR, Duodopa, Sinemet, Sinemet Plus, Sinemet CR, Half Sinemet CR, Lecado, unbranded form)
- co-careldopa plus entacapone (Stalevo)
Although the main treatment for Parkinson 's is medication, there are some types of surgery available to treat the symptoms of the condition, it is generally only used to treat people who have had Parkinson 's for some time and whose symptoms are not managed effectively by medication.
The main types of surgery for Parkinson 's are:
- Deep Brain Stimulation
- Lesioning techniques
Parkinson’s disease is not a condition that is necessarily easy to be diagnosed. Therefore, the individual is advised to see a Parkinson’s specialist to receive the most accurate diagnosis and consider what the best course of treatment for the individual would be.
Parkinson’s disease can come in two forms; there is a late-onset disease, and early-onset disease. Generally, the disease will begin after the age of 50, being the late-onset. In the early-onset cases, they can begin as early as the age of 20, and can be referred to as a juvenile-onset case...
Unfortunately, no treatment has been able to fully cure the disease. Treatment began primitively, consisting of things such as “bloodletting from the neck” which was followed by induced inflammation and blistering to the skin. Today, the most common and effective way of treating Parkinson’s temporarily is through attempting to balance dopamine and acetylcholine levels within the brain by prescribing patients with what is known on the market commonly as Levodopa. It is essentially a dopamine supplement of which’s dosage must be individualized for each different patient since the symptoms vary from person to person (Goldmann, 44). This treatment will eventually become less and less effective as the progression of the disease continues. All that patients and neurologists seem to be able to do is attempt to manage the symptoms it
Varanese, S., Birnbaum, Z., Rossi, R., & Di Rocco, A. (2010). Treatment of Advanced Parkinson's Disease. Parkinson's Disease.
for thousands of years. There is no cure for parkinsons disease but there is treatment as ell as
Parkinson's is an idiopathic, multifactorial neurodegenerative disease that attacks neurotransmitters in the brain called dopamine. Dopamine is concentrated in a specific area of the brain called the substantia nigra. The neurotransmitter dopamine is a chemical that regulates muscle movement and emotion. Dopamine is responsible for relaying messages between the substantia nigra and other parts of the brain to control body movement. The death of these neurotransmitters affects the central nervous system. The most common symptoms are movement related, including shaking, rigidity, slowness of movement and difficulty with posture. Behavioral problems may arise as the disease progresses. Due to the loss of dopamine, Parkinson's patients will often experience depression and some compulsive behavior. In advanced stages of the disease dementia will sometimes occur. The implications of the disease on the anatomy and physiology of the respiratory and phonatory systems significantly control speech.
Michaels, A. (2007, April 22). Drug Treatment for Dementia Sufferers. Article Directory. Retrieved October 19, 2008, from Articlesbase database.
Parkinson’s disease is a chronic, progressive neurodegenerative disorder characterised by resting tremor, slowed movements, rigidity and postural instability (Casey G, 2013). It is the second most common neurodegenerative disorder after Alzheimer’s (Martin and Mills, 2012). There is a great variability in reported incidence rates, probably due to difference in diagnostic criteria and case ascertainment, with reported rates in Australia and in Western countries ranging from 8.6 to 19.0 per 100,000 population (J Macphee and D Stewart, 2012). The two main brain structures affected by Parkinson’s are the substantia nigra pars compacta, which is located in the midbrain and other parts of the basal ganglia, w...
Parkinson disease is their affliction. Although Parkinsonism has been around almost as long as recorded history, there is yet to be found a cause or a cure. Medications tame the symptoms and prolong life, but are incapable of reversing the disease progression.. Diagnosis relies exclusively upon clinical signs and symptoms, because almost all laboratory and radiography tests are normal in the Parkinson patient. For this reason early diagnosis is very difficult.
Parkinson disease begins after the age of 40 years, with peak age of onset between 58 and 62 years. It is slightly more prevalent in males. This disease is one of the most prevalent of the primary CNS disorders and a leading cause of neurologic disability in individuals older than 60 years. The prevalence rate is 107 to 187 per 100,000 persons, with 40,000 new cases in the United States each year.
A Usthemp é uma marca gaúcha de calçados, que se lançou no mercado com a proposta de ter um produto inédito e diferenciado, caracterizado pela exclusividade e personalização. Voltada inicialmente para o comércio on-line, a empresa passou a comercializar os calçados em pontos físicos após uma parceria com a marca Restaura Jeans, que se propôs a reutilizar jeans de calças para a fabricação dos calçados. Com um perfil autêntico e diferenciado, a Usthemp se propõe a vender mais que simplesmente um bom produto, se propõe a oferecer ao consumidor exclusividade, personalização, design arrojado e diferenciação.
Discuss the possible drug and excipient-related constrains of the formulation (no identity of the drug was given to you at this
James Parkinson first discovered Parkinson's Disease in 1817. Parkinson's Disease is a common neurologic disorder for the elderly. It is a disorder of the brain characterized by shaking and difficulty with walking, movement, and coordination. This disease is associated with damage to a part of the brain that controls muscle movement. Parkinson's Disease is a chronic illness that is still being extensively studied.
"Secondary Parkinsonism: MedlinePlus Medical Encyclopedia." U.S National Library of Medicine. U.S. National Library of Medicine, n.d. Web. 11 May 2014.
This therapy is used in dentistry for treating gum diseases, tooth decay and for teeth whitening.